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Chromophore pre-maturation for 
improved speed and sensitivity of 
split-GFP monitoring of protein 
secretion
Magnus Lundqvist1, Niklas Thalén1, Anna-Luisa Volk1, Henning Gram Hansen  2, 
Eric von Otter3, Per-Åke Nygren  1, Mathias Uhlen  1,2,4 & Johan Rockberg1
Complementation-dependent fluorescence is a powerful way to study co-localization or interactions 
between biomolecules. A split-GFP variant, involving the self-associating GFP 1–10 and GFP 11, has 
previously provided a convenient approach to measure recombinant protein titers in cell supernatants. 
A limitation of this approach is the slow chromophore formation after complementation. Here, we 
alleviate this lag in signal generation by allowing the GFP 1–10 chromophore to mature on a solid 
support containing GFP 11 before applying GFP 1–10 in analyses. The pre-maturated GFP 1–10 
provided up to 150-fold faster signal generation compared to the non-maturated version. Moreover, 
pre-maturated GFP 1–10 significantly improved the ability of discriminating between Chinese hamster 
ovary (CHO) cell lines secreting GFP 11-tagged erythropoietin protein at varying rates. Its improved 
kinetics make the pre-maturated GFP 1–10 a suitable reporter molecule for cell biology research in 
general, especially for ranking individual cell lines based on secretion rates of recombinant proteins.
Biologicals and therapeutic proteins in particular are rapidly increasing their share of the pharmaceutical mar-
ket. Due to an increasing global demand, improvements of cell lines and bioprocess methodology are highly 
needed to enhance production capabilities1–3. Chinese hamster ovary (CHO) cells are usually the preferred host 
for production of therapeutic glycoproteins, as these cells are able to provide high product yields and perform 
post-translational processing, in particular glycosylation, similar to human counterparts4. The development of a 
stable cell line for large-scale production typically involves labor-intensive screening of cells from a polyclonal cell 
pool. This comprises many cultivation steps of individual candidate clones where the product titer is assessed by, 
for example, enzyme-linked immunosorbent assays (ELISA)5.
As a convenient alternative to ELISA, we have previously presented a homogenous assay to quantify secreted 
proteins using a split-GFP reporter system6. GFP can be genetically divided into subunits which in practice are 
non-fluorescent until they self-associate. In one such system, GFP is split into two parts: the first part comprises 
the first ten beta sheets of GFP (GFP 1–10 OPT, henceforth referred to as GFP 1–10) while the second part con-
sists of the eleventh sheet (GFP 11)7. GFP 1–10 carries the amino acid residues that make up the non-mature 
framework of the GFP chromophore. The chromophore becomes maturated upon complementation with the 
GFP 11 peptide, which can be genetically fused to a protein of interest. This setup has been used for different 
applications, e.g., solubility assays8, studies of protein aggregation9 and cellular localization10. In our previously 
described method for split-GFP based protein quantification6, GFP 11 is genetically fused to a recombinant pro-
tein destined for secretion. As the protein is secreted into the cell supernatant, it can be fluorescently detected 
and quantified by addition of GFP 1–10. This approach does not require any antibodies or capture/washing steps 
and the GFP 11 tag is small and has been engineered to minimize perturbation on fusion protein folding and 
solubility7. This split-GFP approach for measuring secreted protein titers could also allow for integration with 
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droplet microfluidics for high-throughput screening of live single cells11. This can facilitate the process of find-
ing high-producing clones for therapeutic proteins but also implies a relatively complex environment in which 
detection limits and assay speed become crucial factors. While the binding event between GFP 1–10 and GFP 11 
is relatively fast, the subsequent maturation of the GFP chromophore requires approximately six hours7,12, where 
an autocatalytic cyclization of the three residues which form the chromophore is required13.
The purpose of this work is to investigate if an increased sensitivity and accelerated detection in in vitro 
split-GFP assays could allow for a more reliable way to distinguish between protein secretion rates of different 
cell lines. In a previous study, examining the association and dissociation of split-GFP subunits, it was shown 
that fluorescent and thus maturated complexes between GFP 1–10 and GFP 11 could be disassembled and then 
reassembled and still have the ability to fluoresce14. Different methods has thereafter been used to generate pre-
maturated versions of split-GFP either by producing GFP with an incorporated proteolytic site that allows for the 
release of a beta sheet15 or by co-expressing a fusion protein with the missing GFP strand16. These prematurated 
split-GFP versions have been seen to provide a fluorescent signal more quickly upon complementation compared 
to non-maturated variants.
Here, we describe a new protocol for production of GFP 1–10 proteins with maturated chromophores (hence-
forth referred to as GFP 1–10mat) with the aim to simplify existing protocols, which require more purification 
steps. This is accomplished via capture of inclusion body purified GFP 1–10 on a solid support containing the 
GFP 11 partner, followed by acid elution of GFP 1–10mat and protein refolding. Further, we demonstrate the 
advantages of using GFP 1–10mat in complementation assays involving quantification of GFP 11-tagged recombi-
nant erythropoietin (EPO) secreted from CHO cells.
Results and Discussion
GFP 1–10 and His6-Z_GFP 11 (GFP 11 genetically fused to the C-terminus of the IgG binding Z domain derived 
from protein A) (Fig. 1a) were expressed intracellularly in E. coli. The GFP 1–10 protein was purified from solu-
bilized inclusion bodies and the His6-Z_GFP 11 protein was purified from the soluble fraction by immobilized 
metal ion affinity chromatography (IMAC) (see Supplementary Fig. S1 for SDS-PAGE gel analysis of purified 
proteins).
His6-Z_GFP 11 was covalently coupled to N-hydroxysuccinimide (NHS) activated Sepharose beads (2.5 ml 
of His6-Z_GFP 11 at a concentration of 0.87 mM was added to 5 ml of bead slurry). His6-Z_GFP 11 beads were 
subsequently incubated overnight with a GFP 1–10 solution (40 ml at a concentration of 50 µM) to promote the 
maturation of the GFP 1–10 chromophore. The following day the bead slurry had turned green (data not shown) 
and after washing the GFP 11-bound GFP 1–10mat was eluted by low pH after which the solution pH was adjusted 
to neutral (Fig. 1b).
In order to establish a robust protocol for GFP 1–10 chromophore pre-maturation on beads, various parame-
ters were optimized. Both time and temperature for the incubation with His6-Z_GFP 11-beads were investigated 
and an overnight incubation at room temperature was found to be the most advantageous option (Supplementary 
Fig. S2). In parallel, it was observed that the pre-maturation process did not seem to be light sensitive, as con-
cealing the samples with aluminum foil during chromophore pre-maturation did not show any improvements 
in subsequent assays (Supplementary Fig. S3). As the His6-Z_GFP 11-to-bead ratio increased, the specific yield 
of GFP 1–10mat (based on obtained fluorescence per mg of His6-Z-GFP 11 on beads) decreased. (Supplementary 
Fig. S4). Still, it was decided to use the highest amount tested of His6-Z_GFP 11 (25 mg; 2.5 ml of a concentration 
of 0.87 mM) to 5 ml of bead slurry, as this generated more GFP 1–10mat per preparation. When using these cou-
pling conditions, essentially all His6-Z_GFP 11 was immobilized on the beads (Supplementary Fig. S5). Higher 
His6-Z_GFP 11-to-bead ratios were not tested, as the bead manufacturer did not recommend it. We reused beads 
up to two times and did not see any apparent loss in efficiency (data not shown). Studying bead recycling and stor-
age time of beads more thoroughly could be valuable if larger quantities of GFP 1–10mat are to be made repeatedly.
Supplying 50 mg of GFP 1–10 (40 ml at a concentration of 50 µM) to 5 ml His6-Z_GFP 11-immobilized bead 
slurry resulted in a yield of 1 mg GFP 1–10mat in the eluate. Thus, only 2% of the supplied GFP 1–10 was matu-
rated and recovered from the beads. This low yield of eluted GFP 1–10mat is presumably due to sterical hindrance 
on the beads (Supplementary Fig. S4) and GFP 1–10′s that are not functional due to improper refolding after 
inclusion body purification. Different approaches were evaluated to improve the yield. Urea was tested for GFP 
1–10mat bead elution but provided even lower yields and did not show an enhance detection speed compared to 
non-maturated GFP 1–10. A slight increase in yield was achieved (with guanidine) when using a PierceTM Protein 
Refolding Kit but not enough to deviate from the established protocol for GFP 1–10 refolding (data not shown). 
Higher yields can be achieved with the proteolytic cleavage method though this involves many more purification 
steps15. Nevertheless, in this study, 0.5 µg to 1.5 µg of GFP 1–10mat was typically used for each sample in 96-well 
plates. Thus, one batch of GFP 1–10mat would still be enough for 650 to 2000 wells.
Chromophore formation in GFP implies a weight loss of 20 or 21 Da, corresponding to a loss of one oxygen 
and four or five hydrogen atoms depending on maturation theory13. Successful maturation was confirmed by 
detecting this anticipated mass shift (−20.77 Da) by mass spectrometry (Fig. 2), which indicates a loss of five, and 
not four, hydrogen atoms. In addition, the appearance of only one peak in the MS analysis suggests that all GFP 
11-bound and later eluted GFP 1–10mat protein has undergone the maturation during the overnight incubation.
The kinetics of complementation-dependent fluorescence of GFP 1–10mat and GFP 1–10 were compared 
head-to-head in Tris-NaCl-Glycerol (TNG) buffer by monitoring the increase in fluorescent signal after adding 
His6-Z_GFP 11 (Fig. 3). Samples contained 225 µM His6-Z_GFP 11 and 0.2 µM of either GFP 1–10mat or GFP 
1–10, hence more than a 1000-fold molar excess of His6-Z_GFP 11. The signal for GFP 1–10 increased steadily 
with approximately 0.5 a.u./second until it reached a plateau after ca. five hours, while for GFP 1–10mat, the fluo-
rescent signal increased with 83 a.u./sec during the first two minutes after which the signal continued to increase 
at approx. 6 a.u./sec for an additional hour and later reached a plateau after three hours. Thus, the initial signal 
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formation rate was approx. 150 times faster for the GFP 1–10mat than its non-maturated counterpart. Presumably, 
the slower increase could be the result of a decline in GFP 1–10mat availability or oligomeric complexes17.
Figure 1. Recombinant proteins used in this study and GFP 1–10 pre-maturation scheme. (a) Schematic 
representation of the domains present in the proteins used in this study: (α) GFP 1–10 (β) His6-Z_GFP 11, and 
(γ) EPO_GFP 11. Both His6-Z_GFP 11 and EPO_GFP 11 have a short GS-linkers before GFP 11. (b) Illustration 
of the GFP 1–10 pre-maturation process on a solid support containing His6-Z_GFP 11. (1) The 11th sheet of 
GFP fused to the Z domain derived from protein A (His6-Z_GFP 11) is covalently coupled to Sepharose beads. 
The remaining part of GFP (GFP 1–10) is supplemented to the beads, (2) whereupon the two subunits self-
associate and thereby complete the GFP structure. This initiates the relatively slow rearrangement of covalent 
bonds, which is necessary for the chromophore present in GFP 1–10 to mature. (3) Eventually, GFP 1–10 bound 
to the beads via GFP 11 will start to fluoresce as their chromophores have been maturated. Unbound GFP 1–10 
and other impurities are washed away (4) before the bound GFP 1–10mat is released from GFP 11 by low pH 
and the eluate is neutralized. (5) The released GFP 1–10mat now comprises a maturated chromophore and is 
therefore prone to start fluorescing more rapidly when re-encountering GFP 11.
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When assayed at the same concentration as determined by absorbance at 280 nm and by SDS-PAGE 
(Supplementary Fig. S6), GFP 1–10mat reached a final signal almost four times as high as seen for GFP 1–10. 
Notably, compared to the preparation of GFP 1–10 from inclusion bodies, the maturation protocol involves an 
additional purification step via the GFP 11 during which only the fraction of GFP 1–10 capable of interacting 
with the bead bound GFP 11 is selectively recovered and other impurities are removed. Interestingly, GFP 1–10mat 
gave rise to an approximately 250-fold higher background signal (40,000 a.u. and 150 a.u. for GFP 1–10mat and 
GFP 1–10, respectively). Hence, the eleventh sheet of GFP is not necessary for fluorescence once the chromo-
phore is formed although it enhanced the fluorescence intensity by 3–4 fold (Fig. 3). Higher fluorescence has 
been described before for prematurated GFP 1–1015,16; still, it prompted us to check for co-elution or leakage of 
Figure 2. Confirmation of chromophore maturation by mass spectrometry. A comparison of GFP 1–10 
before (a) and after (b) maturation according to the protocol shows a 21 Da (20.77) reduction in mass 
(white = hydrogen, grey = carbon, blue = nitrogen and red = oxygen). This corresponds to the loss of one 
oxygen and five hydrogen atoms resulting from the cyclization and covalent rearrangement during the 
chromophore maturation process.
Figure 3. Comparison of the kinetics of fluorescent signal generation using GFP 1–10mat and GFP 1–10. GFP 
1–10mat and GFP 1–10 were compared head-to-head in TNG buffer containing His6-Z_-GFP 11. His6-Z_GFP 
11 was excluded in negative controls and the fluorescence from these controls were subtracted from the actual 
samples. Supplementary Fig. S7 presents a plot with raw data for samples and negative controls. After only two 
minutes (the first datapoint), the signal from GFP 1–10mat had increased by more than 10,000 a.u. (83 a.u./sec) 
while the GFP 1–10 steadily increased with only 0.5 a.u./sec until its maximum., thereby making the mature 
version up to 150-fold faster. Furthermore, the GFP 1–10mat presented a final signal almost four times greater 
than observed for the GFP 1–10.
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His6-Z_GFP 11 from the beads used during maturation. However, no such remains were detected by Western blot 
(Supplementary Fig. S8). The increase in background signal did however not cause any constraints for the assays 
in this study.
We then examined the emission and excitation spectra of both GFP 1–10 variants (Supplementary Fig. S9). 
Without His6-Z_GFP 11, non-maturated GFP 1–10 did not fluoresce, while GFP 1–10mat showed an excitation 
plateau around 460–490 nm. Upon addition of His6-Z_GFP 11, both GFP 1–10 variants showed similar spectra 
with a peak at 488 nm. Furthermore, GFP 1–10mat with His6-Z_GFP 11 had an increased signal over the entire 
spectra compared to the background signal of GFP 1–10mat without His6-Z_GFP 11, but in particular around the 
excitation peak at 488 nm.
To test GFP 1–10mat in a more complex setup, three stable CHO cell lines with different specific productivities 
of recombinant EPO genetically fused to GFP 11 (EPO_GFP 11) were cultivated in a 96-well plate with either 
GFP 1–10mat or GFP 1–10 present in the culture medium from the start (Fig. 4). The specific productivities of the 
low, medium and high producer cell lines had previously been determined to be “below limit of detection”, 0.2 pg/
Figure 4. GFP 1–10mat was superior to non-maturated GFP 1–10 for distinguishing between recombinant EPO 
secretion from CHO cells. CHO cell lines expressing recombinant EPO, genetically tagged with GFP 11, were 
cultured in microtiter plates with either GFP 1–10mat or GFP 1–10 protein present in the medium from the start 
and expression was monitored over time. Secreted EPO-GFP 11 resulted in GFP 1–10 complementation and 
thereby a fluorescent signal. Three strains with different specific productivities were monitored: low producer 
(“efficiency too low to measure”); medium producer (0.2 pg/cell/day); and high producer (1.5 pg/cell/day). 
Cultures were run in triplicates and signal values analyzed with a two-tailed, unpaired t-test. To be qualified as 
differentiable at a certain time point, a p-value below 0.05 was required also for all following time points. (a) 
Using GFP 1–10, it was not possible to discriminate between the cell lines. (b) Using GFP 1–10mat, it was already 
from the first time-point possible to distinguish between the high and medium producers, and after 5 hours, it 
was likewise possible to distinguish the signal between the medium and low producing strains.
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cell/day and 1.5 pg/cell/day, respectively. With GFP 1–10 present in the culture medium, a statistically reliable 
separation of the productivities between the cell lines was not possible at any timepoint. However, with GFP 
1–10mat present, a clear and statistically distinct separation of the productivities could immediately be observed 
between the high and medium producer cell lines, while the medium and low producer could be differentiated 
after five hours.
It would be interesting to use our methodology also on other split versions of fluorescent proteins, for example 
split-mNeonGreen21–10/1118, which could provide a brighter fluorescent signal in vitro compared to GFP 1–10. 
Other circulated permuted variants of GFP could be tested16,19. Another possible route for developing a faster split 
GFP system is to develop a split version of TurboGFP as it has an inherent rapid maturation20 which may allow 
its use in product titer assays without a pre-maturation step. However, establishing a split version of TurboGFP 
might be precarious as TurboGFP is more prone to aggregation compared to superfolder GFP, which was used as 
starting-point for the GFP 1–10 and GFP 11 fragments in this study.
In summary, our strategy to subject GFP 1–10 to a combined pre-maturation and purification step on GFP 11 
beads gave rise to up to a 150-fold faster rate of fluorescence complementation compared to its non-maturated 
counterpart. Moreover, less GFP 1–10mat protein was needed to reach fluorescent signals distinguishable over 
background. Additionally, the GFP 1–10mat variant made it possible to discriminate between CHO cell lines with 
different specific productivities of EPO_GFP 11 by monitoring fluorescence in the cell supernatant in real-time.
In conclusion, we recommend the use of GFP 1–10mat for studies where a faster detection and/or improved 
sensitivity is needed. We especially envision it to be beneficial for sorting of live cells in droplet microfluidics 
settings based on protein secretion as it allows for significantly shorter incubation times.
Materials and Methods
GFP 1–10 and His6-Z_GFP 11 production. The gene encoding the GFP 1–10 construct used in the exper-
iments was ordered from DNA2.0 (ATUM) and corresponds to the GFP 1–10 OPT (in the manuscript simply 
referred to as GFP 1–10) sequence described earlier7. The GFP 1–10 gene was expressed in E. coli BL21 (DE3) 
cells using the PJExpress411-Kan vector (ATUM) based on the T7 promoter, and was purified from cell pellets 
from 500 ml cultivations in accordance with Cabantous et al.21 although 150 mg of pellets were made instead of 
75 mg. His-tagged Z_GFP 11 was expressed in E. coli BL21 cells. 500 µl of overnight culture was used to inocu-
late 500 ml of TSB + Y media with ampicillin (0.1 mg/ml). Cells were maintained at 37 °C and 150 rpm, induced 
with IPTG (final concentration 1 mM) at OD600 = 1 and harvested the following day. Cells were spun down at 
15,000 g for 20 minutes and pellet was stored at −20 °C. Pellet was thawed in 2.5 ml BugBuster/g wet cell weight, 
vortexed and incubated at room temperature for 20 minutes before spun down 15,000 for 20 minutes. Supernatant 
containing His6-Z_GFP 11 was filtered (0.45 µm) and purified on an ÄKTA start (GE Healthcare) using a HiTrap 
Nickel FF (cv 1 ml). Protein was eluted in 1 ml fractions using a 0–500 nM imidazole gradient. Eluted protein was 
buffer exchanged to coupling buffer (0.2 M NaHCO3, 5.5 M NaCl, pH 8,3) on a PD-10 column (GE Healthcare). 
Protein concentrations were determined by absorbance at 280 nm on an Eppendorf BioPhotometer (Eppendorf). 
See Supplementary Table T1 for amino acid sequences.
Bead coupling. His6-Z_GFP 11 was covalently coupled to NHS-activated Sepharose beads (GE Healthcare). 
5 ml of beads were washed 5 times with 10 ml HCl (1 mM), before His6-Z_GFP 11 in coupling buffer was added 
(0.87 mM, 2.5 ml). Coupling reaction proceeded for 2 hours at room temperature on a rolling mixer before block-
ing buffer (0.1 M Tris-HCl pH 8.5) was added. Blocking occurred for 2.5 hours on a rolling table. Beads were 
washed with 10 ml high pH buffer (0.1 M Tris-HCl pH8.5) and then 10 ml low pH buffer (0.1 M acetate buffer, 
0.5 M NaCl pH 4.0). This wash was repeated five times. Finally, beads were stored in PBS with 20% ethanol.
GFP 1–10 pre-maturation. Approximately 50 mg of purified GFP 1–10 in 40 ml TNG buffer (50 mM Tris, 
pH 7.4, 0.1 M NaCl, and 10% glycerol) was added to 4 ml of coupled beads in a 50 ml Falcon tube and left at room 
temperature on a rolling table overnight. To clear away non-maturated GFP 1–10, beads were spun down at 
1000 rcf for four minutes whereupon the supernatant was removed and beads were resuspended in 40 ml TNG 
buffer. This washing procedure was repeated twice. GFP 1–10mat was released from the beads with 2 ml glycine 
buffer (0.1 M, pH 2.0), spun down at 1000 rcf for 4 minutes, and supernatant was neutralized with 2 ml Tris buffer 
(0.5 M, pH 7.8). This procedure was repeated two more times. Neutralized samples were then filtered (0.45 µm) 
and buffer exchanged on PD-10 column (GE Healthcare) to TNG buffer. Beads have been reused for at least two 
times with no apparent loss in efficiency. To recycle beads, they were washed three times with 40 ml of the glycine 
buffer and one time with 40 ml TNG buffer (spun down at 1000 rcf for 4 minutes between the washes). Finally, 
beads were stored in 1xPBS with 20% ethanol at 4 °C.
Mass-spectrometry. GFP 1–10mat and GFP 1–10 were buffer exchanged to MilliQ water. Subsequently, 
320 µl of GFP 1–10 samples were mixed with 80 µl of 20% acetonitrile (with 0.1% Trifluoroacetic acid) and puri-
fied by RP-HPLC on an analytical column (Zorbax 300SB-C18 4.6 × 150 mm, 3.5 µm particle size, Agilent) using 
a 30 min gradient of 20–50% buffer B (0.1% TFA in ACN) with a flow-rate of 1.0 ml/min before analyzed by liquid 
chromatography electrospray ionization mass spectrometry (LC-ESI-MS) on a 6520 Accurate-mass Q-TOF LC/
MS (Agilent).
Split-GFP fluorescent complementation assay. The split-GFP complementation assay was carried out 
in triplicates for both GFP 1–10 variants. Wells were blocked with 5% BSA in TNG buffer for 10 minutes before 
the samples were added. Each replicate had a total volume of 100 µl TNG buffer with 225 µM His6-Z_GFP 11 and 
0.2 µM GFP 1–10. His6-Z_GFP 11 was added to the wells (5 µl) before GFP 1–10 (95 µl). The first measurement 
was done after two minutes. In negative controls, His6-Z_GFP 11 was excluded and fluorescence from these 
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controls were subtracted from the actual samples. Measurements were performed at 25 °C every 3 minutes on a 
CLARIOstar® plate reader (BMG Labtech) at 488 ± 8 nm excitation and 535 ± 30 nm emission.
EPO_GFP 11-producing CHO cell lines. CHO-S cells were cultivated and transfected essentially as pre-
viously described using FreeStyle MAX reagent with an EPO-GFP 11-encoding plasmid harboring a neomycin 
resistance cassette6. This plasmid was constructed essentially like previously described6. Geneticin-selected cells 
were single cell-sorted on a BD FACSJazz cell sorter (BD Biosciences, San Jose, CA) and three randomly picked 
clones were further characterized in 6-well plates. Viable cell density was measured daily using the previously 
described Celígo-based method6. Supernatant (2000 g, RT, 5 min) was obtained three days after seeding for EPO 
titer analysis performed on an Octet RED96 (Pall ForteBio, Fremont, CA, USA) as described before22. Integral of 
viable cell density (IVCD) and daily specific production rate were calculated as described elsewhere23.
Monitoring secretion rate of EPO_GFP 11 by fluorescent complementation. A black 96-well 
plate (Nunc) was blocked with 0.5% BSA in TNG buffer for 1.5 h. 50 µL of a 1.6*107 cells/mL cell suspension in 
fresh medium was added to the blocked plate and mixed with 50 µL of either mature or non-mature GFP 1–10 
to yield a final concentration of 15 µg/mL 0.6 µM GFP 1–10. The plate was kept in a CLARIOstar® plate reader 
(BMG Labtech) for 7 h, at 25 °C and atmospheric CO2 concentration with constant shaking between the measure-
ments. GFP fluorescence was measured at 25 °C every 15 minutes for 7 hours in a CLARIOstar® plate reader at 
488 ± 8 nm excitation and 535 ± 30 nm emission.
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